Coincidental or ??? Mateon filings

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

l2007s

Rank: President [?]

Points: 18410 [?]

Votes: 123 Score: 3.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Coincidental or ??? Mateon filings

posted on Aug 24, 2020 12:08PM

Steven King sits on the BoD of Mateon Therapeutics. Take a look at their recent 8K filings.

Steven King is also listed as a member of the Rapid Response team for Covid 19 for Oncotelic which is a subsidiary of Mateon.

http://investor.mateon.com/sec-filings

Also from the above referenced filings

Provisional Patent Filing On August 18, 2020 Oncotelic, Inc. (“Oncotelic”), a wholly-owned subsidiary of Mateon Therapeutics, Inc. (“Mateon” or the “Company”), filed a provisional patent application on the method of use and composition of matter for second generation COVID-19 vaccine leveraging on OT-101 as adjuvant. To avoid the two potential issues wiith 1st generation vaccine against COVID-19, we will be combining the 1st generation COVID-19 DNA vaccine with a TGF-β inhibitor (OT-101) to stimulate a strong immune response while suppressing the IgA class switching that could aggravate the disease through Kawasaki reaction- IgA vasculitis. The company is aggressively pursuing the development of this 2 nd generation COVID-19 vaccine expecting that the 1 st generation vaccines would not be fully effective and may not be sufficient to counter the current pandemic.